Herein we found a potential regulatory subnetwork, RBM6-CDKN2A-MRPL10-MARCKSL, which is highly correlated with melanoma patients’ survival rate (P-value = 0.019, log rank test. This evidence concerns the gene CDKN2A and melanoma.